1. Al-Turki, D.A., M.A. Al-Omar, L.A. Abou-Zeid, I.A. Shehata and M.S. Al-Awady, 2017. Design, synthesis, molecular modeling and biological evaluation of novel diaryl heterocyclic analogs as potential selective cyclooxygenase-2 (COX-2) inhibitors. Saudi Pharmaceut. J., 25: 59-69.
   CrossRef  |  Direct Link  |  
2. Osama, L., L.A. Abou-Zeid, M.N.A. Nasr and A.S. Tantawy, 2016. Synthesis and molecular modeling of new quinoline derivatives as antitumor agents. Der Pharma Chemica, 8: 100-110.
   Direct Link  |  
3. Alaa, A.M., L.A. Abou-Zeid, K.E.H. ElTahir, R.R. Ayyad, A.A. Magda and A.S. El-Azab, 2016. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones. Eur. J. Med. Chem., 121: 410-421.
   CrossRef  |  Direct Link  |  
4. Alaa, A.M., L.A. Abou-Zeid, K.E.H. ElTahir, M.A. Mohamed, M.A.A. El-Enin and A.S. El-Azab, 2016. Design, synthesis of 2,3-disubstitued 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents: COX-1/2 inhibitory activities and molecular docking studies. Bioorg. Med. Chem., 24: 3818-3828.
   CrossRef  |  PubMed  |  Direct Link  |  
5. Alaa, A.M., A.S. El-Azab, L.A. Abou-Zeid, K.E.H. ElTahir, N.I. Abdel-Aziz, R.R. Ayyad and A.M. Al-Obaid, 2016. Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies. Eur. J. Med. Chem., 115: 121-131.
   CrossRef  |  Direct Link  |  
6. Kosbar, T.R., M.A. Sofan, L. Abou-Zeid and E.B. Pedersen, 2015. Thermal stability of G-rich anti-parallel DNA triplexes upon insertion of LNA and α-L-LNA. Org. Biomol. Chem., 13: 5115-5121.
   CrossRef  |  Direct Link  |  
7. Alter, G.M. and L. Abou-Zeid, 2015. Molecular dynamic simulation of malate dehydrogenase. SMU Med. J., 2: 270-280.
   Direct Link  |  
8. Abouzeid, L.A. and H.I. El-Subbagh, 2015. DNA binding of ethyl 2-substituted aminothiazole-4-carboxylate analogues: A molecular modeling approach to predict their antitumor activity. Future J. Pharmaceut. Sci., 1: 1-7.
   CrossRef  |  Direct Link  |  
9. Abou-Zeid, L.A. and M. Hefnawy, 2015. Molecular modeling study of the chiral recognition of celiprolol enantiomers by a β-cyclodextrin. Pharmaceut. Chem. J., 2: 16-23.
   Direct Link  |  
10. Henen, M.A., L. Abou-Zeid, A.E.D. Barghash and H. Eisa, 2014. ¹⁹F-NMR as a powerful tool for measuring binding of synthesized small combinatorial dynamic library components with the armadillo repeat domain of human β-catenin. Curr. Top. Pept. Protein Res., 15: 35-39.
    Direct Link  |  
11. El-Feky, S.M., L.A. Abou-Zeid, M.A. Massoud, S.K. George and H.M. Eisa, 2014. Computational design, molecular modeling and synthesis of new 1,2,4-triazole analogs with potential antifungal activities. SMU Med. J., 1: 224-242.
    Direct Link  |  
12. Abou-Zeid, L. and H.N. Baraka, 2014. Combating oxidative stress as a hallmark of cancer and aging: Computational modeling and synthesis of phenylene diamine analogs as potential antioxidant. Saudi Pharmaceut. J., 22: 264-272.
    CrossRef  |  Direct Link  |  
13. Shuhnna, M., A. Dauood, L. Abouzeid and O. Khudro, 2013. Synthesis and molecular modeling for novel derivative of benzodiazepines and determine the structure using spectrum methods. Res. J. Aleppo Univ., 88: 49-53.
14. Shuhnna, M., A. Dauood, L. Abouzeid and O. Khudro, 2013. Analytical method validation and stability study for novel derivative of benzodiazepines. Res. J. Aleppo Univ., 88: 45-48.
15. Kosbar, T., M. Sofan, L. Abou-Zeid, M. Waly and E.B. Pedersen, 2013. Highly efficient synthesis of allopurinol locked nucleic acid monomer by C6 deamination of 8-aza-7-bromo-7-deazaadenine locked nucleic acid monomer. Synthesis, 45: 3259-3262.
    CrossRef  |  Direct Link  |  
16. Henen, M.A., L. Abou-Zeid, A.E.D. Barghash and H.M. Eisa, 2013. Nuclear magnetic resonance as a breakthrough frontier in fragment-based drug design. J. Am. Sci., 9: 459-466.
    Direct Link  |  
17. Bayomi, S.M., H.A. El-Kashef, M.B. El-Ashmawy, M.N.A. Nasr and M.A. El-Sherbeny et al., 2013. Synthesis and biological evaluation of new curcumin derivatives as antioxidant and antitumor agents. Med. Chem. Res., 22: 1147-1162.
    CrossRef  |  Direct Link  |  
18. Waly, M.A., L. Abou-Zeid, S.R. El-Gogary and M.A. Shalaby, 2012. One-pot synthesis, molecular modeling and in vitro antibacterial activity of novel 3-(1,3,4-oxadiazol-2-yl)quinoxaline 1,4-dioxide and pyrazolyl analogs. Acta Chimica Slovenica, 59: 32-41.
    Direct Link  |  
19. El Sayed, M.A.A., M.A. Massoud, A.S. Tantawy, M.N.A. Nasr, A.E.D.M. Barghash and L.A. Abou-Zeid, 2012. Synthesis and biological evaluation of new unsaturated derivatives of cyclic compounds as potent antioxidant agent. Der Pharma Chemica, 5: 1785-1797.
    Direct Link  |  
20. Bayoumi, W.A., M.A. Elsayed, H.N. Baraka and L. Abou-Zeid, 2012. Computational modeling, synthesis and antioxidant potential of novel phenylcarbamoylbenzoic acid analogs in combating oxidative stress. Archiv Pharmazie, 345: 902-910.
    CrossRef  |  Direct Link  |  
21. Youssef, K.M., M.A. Al-Omar, H.I. El-Subbagh, L.A. Abou-Zeid, A.G.M. Abdel-Gader, N.G. Haress and A.S. Al-Tuwaijri, 2011. Synthesis, antiplatelet aggregation activity and molecular modeling study of novel substituted-piperazine analogues. Med. Chem. Res., 20: 898-911.
    CrossRef  |  Direct Link  |  
22. El-Feky, S.M., L.A. Abou-Zeid, M.A. Massoud, S.K. George and H.M. Eisa, 2010. Synthesis, molecular modeling of novel 1,2,4-triazole derivatives with potential antimicrobial and antiviral activities. Acta Pharmaceutica Sciencia, 52: 353-364.
23. Al-Turki, D.A., L.A. Abou-Zeid, I.A. Shehata and M.A. Al-Omar, 2010. Therapeutic and toxic effects of new NSAIDs and related compounds: A review and prospective study. Int. J. Pharmacol., 6: 813-825.
    CrossRef  |  Direct Link  |  
24. Al-Omary, F.A., L.A. Abou-Zeid, M.N. Nagi, E.S.E. Habib and A.M. Alaa et al., 2010. Non-classical antifolates. Part 2: synthesis, biological evaluation and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones. Bioorg. Med. Chem., 18: 2849-2863.
    CrossRef  |  Direct Link  |  
25. Goda, F.E., A.S. Tantawy, S., L.A. Abou-zeid, S.M. Badr and K.B. Selim, 2008. Synthesis, biological evaluation and molecular modeling investigation of some new benzimidazole analogs as antiviral agents. Saudi Pharm. J., 16: 103-111.
    Direct Link  |  
26. Abou-Zeid, L.A., A.M. El-Mowafy, D. Eikel, H. Nau and M. El-Mazar, 2007. Computational characteristics of valproic acid binding to Histone deacetylase. Saudi Pharm. J., 15: 183-189.
    Direct Link  |  
27. Abou-Zeid, L., A.M. El-Mowafy, D. Eikel, H. Nau and M.M.A. Elmazar, 2007. Mechanism of butyrate binding to histone deacetylase (HDAC): Correlation with chemopreventive effects and ligand selectivity. J. Basic Appl. Sci., 3: 73-80.
28. Al-Rashood, S.T., I.A. Aboldahab, M.N. Nagi, L.A. Abou-zeid and A.M. Abdel-Aziz et al., 2006. Synthesis, dihydrofolate reductase inhibition, antitumor testing and molecular modeling study of some new 4(3H)-quinazolinone analogs. Bioorg. Med. Chem., 15: 8608-8621.
    PubMed  |  
29. Abou-Zeid, L.A. and A.M. El-Mowafy, 2004. Differential recognition of resveratrol isomers by the human estrogen receptor-α: Molecular dynamics evidence for stereoselective ligand binding. Chirality, 16: 190-195.
    CrossRef  |  Direct Link  |  
30. El-Mowafy, A.M., L.A. Abou-Zeid and I. Edafiogho, 2002. Recognition of resveratrol by the human estrogen receptor-alpha: A molecular modeling approach to understand its biological actions. Med. Principles Pract., 11: 86-92.
    CrossRef  |  Direct Link  |  
31. Abou-Zeid, L.A., 2002. Molecular modeling studies of resveratrol as an estrogen receptor ligand. Saudi Pharm. J., 10: 60-64.
32. Abou-Zeid, L.A. and A.M. El-Mowafy, 2002. Molecular dynamics simulation characteristics of resveratrol interaction with human estrogen receptor-α: Distinct recognition from diethylstilbestrol. J. Mol. Struct.: THEOCHEM, 593: 39-48.
    CrossRef  |  Direct Link  |  
33. Abou-Zeid, L.A. and A.M. El-Mowafy, 2001. Antineoplastons: Major players in the biochemical defensive system against cancer. Saudi Pharmaceut. J., 9: 67-71.
34. Abou-Zeid, L., A.M. El-Mowafy, M.M. El-Kerdawy, H. Hamza and M.E. Abdel-Hamid, 2001. Synthesis, spectroscopic characterization, stability assessment and DNA-binding of new 2,6-piperidinedione derivatives. Il Farmaco, 56: 763-770.
    CrossRef  |  Direct Link  |  
35. Badria, F., M. Mabed, W. Khafagy and L. Abou-Zeid, 2000. Potential utility of antineoplaston A-10 levels in breast cancer. Cancer Lett., 155: 67-70.
    CrossRef  |  Direct Link  |  
36. Badria, F., M. Mabed, M. El-Awadi, L. Abou-Zeid, E. Al-Nashar and S. Hawas, 2000. Immune modulatory potentials of antineoplaston A-10 in breast cancer patients. Cancer Lett., 157: 57-63.
    CrossRef  |  Direct Link  |  
37. Abou-Zeid, L.A., A.M. El-Mowafy, M.B. El-Ashmawy, L.B. Hendry, A.M. Abdelal and F.A. Badria, 2000. Novel piperidinedione analogs as inhibitors of breast cancer cell growth. Archiv Pharmazie, 333: 431-434.
    PubMed  |  
38. El-Kerdawy, M.M., A.S. Tantawy, M.A.M. Massoud and L.A. Abou-Zeid, 1999. Synthesis and antithyroid activity of certain uracil and thiouracil derivatives. Alexandria J. Pharmaceut. Sci., 13: 121-124.
39. El-Kerdawy, M.M., A.S. Tantawy, M.A. Massoud and L.A. Abou-Zeid, 1999. Synthesis and antithyroid activity of certain uracil derivatives (part II). Mansoura Sci. Bull., 26: 133-140.